Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Grifols, S.A.

Capitalization 566.21Cr 650.07Cr 512.67Cr 489.1Cr 889.71Cr 60TCr 922.46Cr 6.09TCr 2.42TCr 29TCr 2.44TCr 2.39TCr 1,03600Cr P/E ratio 2026 *
12.1x
P/E ratio 2027 * 8.29x
Enterprise value 1.43TCr 1.64TCr 1.29TCr 1.23TCr 2.24TCr 1,51400Cr 2.33TCr 15TCr 6.11TCr 72TCr 6.15TCr 6.02TCr 2,61200Cr EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.61x
Free-Float
79.4%
Yield 2026 *
2.85%
Yield 2027 * 2.68%
1 day+1.27%
1 week-6.15%
Current month-12.40%
1 month-15.65%
3 months-13.82%
6 months-23.23%
Current year-12.97%
1 week 9.16
Extreme 9.156
10.06
1 month 9.16
Extreme 9.156
11.44
Current year 9.16
Extreme 9.156
11.7
1 year 7.32
Extreme 7.324
13.7
3 years 6.36
Extreme 6.362
15.92
5 years 6.36
Extreme 6.362
25.94
10 years 6.36
Extreme 6.362
34.31
Manager TitleAgeSince
Chief Executive Officer 57 01/04/2024
Chief Tech/Sci/R&D Officer 52 01/09/2024
Comptroller/Controller/Auditor 47 01/01/2016
Director TitleAgeSince
Chairman 76 25/01/2010
Director/Board Member 70 13/04/2000
Director/Board Member 62 24/05/2015
Change 5d. change 1-year change 3-years change Capi.($)
+1.02%-6.15%-2.04%+3.97% 647.76Cr
+1.48%-3.21%+11.51%+0.91% 7.65TCr
+2.12%-0.59%+37.82%+221.36% 5.44TCr
-1.51%+56.80%+56.80%+56.80% 4.91TCr
-0.26%-3.84%-43.75%-50.49% 4.75TCr
+1.35%-2.35%+28.05%-30.70% 2.66TCr
+0.07%-5.67%+51.48%-65.36% 2.08TCr
+0.23%-4.51%+49.52%+25.35% 1.84TCr
+4.02%+0.96%+105.37%+96.96% 1.79TCr
+0.86%+0.05%+31.01%+53.03% 1.37TCr
Average +0.96%-2.51%+32.58%+31.18% 3.31TCr
Weighted average by Cap. +0.83%-1.96%+26.18%+40.06%

Financials

2026 *2027 *
Net sales 782.17Cr 898.01Cr 708.21Cr 675.65Cr 1.23TCr 83TCr 1.27TCr 8.42TCr 3.34TCr 40TCr 3.37TCr 3.3TCr 1,43100Cr 839.77Cr 964.15Cr 760.38Cr 725.41Cr 1.32TCr 89TCr 1.37TCr 9.04TCr 3.59TCr 43TCr 3.62TCr 3.54TCr 1,53600Cr
Net income 54Cr 62Cr 49Cr 47Cr 85Cr 5.75TCr 88Cr 583.8Cr 231.99Cr 2.75TCr 233.79Cr 228.85Cr 9.92TCr 75Cr 86Cr 68Cr 64Cr 117.18Cr 7.9TCr 121.49Cr 802.35Cr 318.83Cr 3.78TCr 321.31Cr 314.52Cr 14TCr
Net Debt 862.1Cr 989.78Cr 780.59Cr 744.7Cr 1.35TCr 91TCr 1.4TCr 9.28TCr 3.69TCr 44TCr 3.71TCr 3.64TCr 1,57700Cr 786.93Cr 903.47Cr 712.52Cr 679.76Cr 1.24TCr 83TCr 1.28TCr 8.47TCr 3.36TCr 40TCr 3.39TCr 3.32TCr 1,43900Cr
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (85.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (3%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (2.9%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.9%), European Union (15.5%), the United States and Canada (56.7%) and other (21.9%).
Employees
25,258
Date Price Change Volume
16/26/16 9.312 +1.02% 21,01,368
13/26/13 9.218 -0.67% 15,82,325
12/26/12 9.280 -2.07% 25,30,441
11/26/11 9.476 -2.61% 35,49,236
10/26/10 9.730 -1.94% 35,37,695
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
9.218EUR
Average target price
15.05EUR
Spread / Average Target
+63.22%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW